Home / Intelligence / Webinars / Picking Winners: Portfolio Management for a New Era
May 30, 2024 | 1:00 - 1:45 PM ET
Two additional sessions will be offered:
June 4, 2024 | 16:00-16:45 (UTC+8:00) – Asia/Shanghai
June 4, 2024 | 15:00-15:45 CET – Europe/Berlin
Did you know 62% of products launched between September 2019 and December 2021 underperformed expectations in the first year of launch?
What is going wrong, and how can we get it right? Join Trinity Life Sciences for a thought-provoking webinar to dive into the first white paper in our Industry Impact Series, Picking Winners: Portfolio Management for a New Era.
Hear from Trinity’s Leslie Orne, President & CEO, Herman Sanchez, Chief Business Officer and Chad Faulkner, Partner, as they explore the challenges biopharma companies are facing and approaches to enable true innovation that yields clinical and commercial value.
This Webinar is part of Trinity’s Industry Impact Thought Leadership Series
Featuring
Leslie Orne
President & CEO
and Board Member
Herman Sanchez
Chief Business Officer
Chad Alan Faulkner
Partner
Which session would you like to register for?
Complete the form below to register for the May 30th session at 1:00 PM ET
Complete the form below to register for the June 4th session at 16:00 UTC+8 – Asia/Shanghai
Complete the form below to register for the June 4th session at 15:00 CET – Europe/Berlin
We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
White Papers
Picking Winners: Portfolio Management for a New Era
The biopharmaceutical industry is known for its promise of life-changing innovations, but many companies continue to advance the wrong therapies into the clinic, resulting in underperformance and wasted resources. This white paper explores the concentration of activity on well-trodden ground, and the lack of focus on true innovation. With increasing global pricing pressures and policy […]
Read More
Webinars
Learn From the Past – Launch Better Tomorrow
Available On Demand
Whether you are an emerging, mid-tier or large-tier company preparing for launch, this webinar is a must-watch. Join us for an informative webinar as our experts dive into Trinity Life Sciences’ latest white paper, the Trinity Annual Drug Index—an evaluation of commercial performance over three years of 58 novel drugs approved in 2020. Hear from […]
Watch Now
White Papers
Trinity Annual Drug Index
This report, the sixth in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the commercial performance over three years of novel drugs approved by the FDA in 2020, with commercial, therapeutic […]
Read More